TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo

author
created [InstanceEdit:9702968] Rothfels, Karen, 2020-10-03
dbId 9702964
displayName TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo
journal Blood
pages 1525-34
pubMedIdentifier 24408321
schemaClass LiteratureReference
title TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo
url http://www.ncbi.nlm.nih.gov/pubmed/24408321
volume 123
year 2014
Cite Us!